1/16
10:39 am
pcrx
Do Options Traders Know Something About Pacira BioSciences Stock We Don't? [Yahoo! Finance]
Low
Report
Do Options Traders Know Something About Pacira BioSciences Stock We Don't? [Yahoo! Finance]
1/13
08:00 am
pcrx
Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
Medium
Report
Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
1/9
11:37 pm
pcrx
How Investors May Respond To Pacira BioSciences (PCRX) Activist Pressure Amid Buybacks And Rising EXPAREL Revenue [Yahoo! Finance]
Medium
Report
How Investors May Respond To Pacira BioSciences (PCRX) Activist Pressure Amid Buybacks And Rising EXPAREL Revenue [Yahoo! Finance]
1/9
08:02 am
pcrx
Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
Low
Report
Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
1/9
08:02 am
pcrx
Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Low
Report
Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
1/8
05:53 pm
pcrx
Pacira drops after adjusting 2025 revenue below consensus [Seeking Alpha]
Low
Report
Pacira drops after adjusting 2025 revenue below consensus [Seeking Alpha]
1/8
04:56 pm
pcrx
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues [Yahoo! Finance]
High
Report
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues [Yahoo! Finance]
1/8
04:01 pm
pcrx
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
Medium
Report
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
1/8
11:32 am
pcrx
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors [Yahoo! Finance]
Low
Report
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors [Yahoo! Finance]
1/7
08:00 am
pcrx
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
Low
Report
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
12/30
11:02 am
pcrx
DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc. [Yahoo! Finance]
Low
Report
DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc. [Yahoo! Finance]
12/30
10:41 am
pcrx
DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.
Low
Report
DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.
12/18
08:00 am
pcrx
Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
Low
Report
Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
12/10
07:18 am
pcrx
Pacira BioSciences (NASDAQ:PCRX) was upgraded by analysts at Barclays PLC to a "hold" rating.
Low
Report
Pacira BioSciences (NASDAQ:PCRX) was upgraded by analysts at Barclays PLC to a "hold" rating.
12/10
04:10 am
pcrx
Pacira BioSciences (NASDAQ:PCRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Pacira BioSciences (NASDAQ:PCRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
12/9
09:06 am
pcrx
Pacira BioSciences (NASDAQ:PCRX) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $27.00 price target on the stock.
Low
Report
Pacira BioSciences (NASDAQ:PCRX) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $27.00 price target on the stock.
12/3
08:00 am
pcrx
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/2
08:36 pm
pcrx
Does Pacira's ioveradeg Pilot Data and Smart Tip Clearance Change The Bull Case For Pacira (PCRX)? [Yahoo! Finance]
Low
Report
Does Pacira's ioveradeg Pilot Data and Smart Tip Clearance Change The Bull Case For Pacira (PCRX)? [Yahoo! Finance]
12/2
08:00 am
pcrx
Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
Low
Report
Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
11/26
05:38 pm
pcrx
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical [Yahoo! Finance]
Low
Report
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical [Yahoo! Finance]
11/26
04:01 pm
pcrx
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
Low
Report
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
11/18
01:18 pm
pcrx
Pacira BioSciences (NASDAQ:PCRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Pacira BioSciences (NASDAQ:PCRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
08:06 am
pcrx
Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Low
Report
Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
11/11
09:51 am
pcrx
Pacira BioSciences gains as investor calls for full sales process [Seeking Alpha]
Low
Report
Pacira BioSciences gains as investor calls for full sales process [Seeking Alpha]
11/11
08:00 am
pcrx
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
Medium
Report
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences